International compounding regulations — 6 month update

pete_nash said:

Resolution therefore closed the doors unevenly, and the asymmetry follows from the bulks lists.

International shipping tracking for cross-border ordering orders: my experience with customs in the US when ordering from overseas:

Seized and destroyed — had to get a reshipped package.

Tips: always include a copy of your prescription, declare medication properly on customs forms, keep quantities reasonable (personal use = 3 month supply max), and use a vendor who has experience shipping to your country.

tane_welly said:

Agreed, and the enforcement dates were staggered by category — 503A first, 503B a few weeks later — because outsourcing facilities have manufactured…

Genuinely useful, thank you. I had the facts and not the framework. Sending this to two other people who asked me the same thing last week.

pete_nash said:

Resolution therefore closed the doors unevenly, and the asymmetry follows from the bulks lists.

This is where I part company with the consensus forming above. A research-chemical supplier selling lyophilised powder labelled research use only is not compounding and is not claiming to. It is a different legal universe with no pharmacy oversight, no patient relationship and no content guarantee, and conflating the two in these threads helps nobody.

Adding the numbers, since they settle part of this. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

Correct me if the detail matters more than I have assumed.

Moderator note: the sourcing question belongs in the vendor section and has been split out.